Viral and Non-viral Vectors in Gene Therapy: Technology Development and Clinical Trials
Open Access
- 1 October 2003
- journal article
- research article
- Published by SAGE Publications in Technology in Cancer Research & Treatment
- Vol. 2 (5) , 471-485
Abstract
Gene therapy as part of modern molecular medicine holds great promise for the treatment of both acute and chronic diseases and has the potential to bring a revolutionary era to cancer treatment. Gene therapy has been named the medicine of the future. For the past 10 years various viral and non-viral vectors have been engineered for improved gene and drug delivery. Although various diseases have been targeted, cancer therapy has been addressed to a large extent because of the straight forward approach. Delivery of toxic or immunostimulatory genes by viral and non-viral vectors has been investigated and encouraging results have been obtained in animal models. A large number of clinical trials have been conducted with some highly promising outcome. We propose that combinations of viruses with lipo-somes or polymers will solve the problem of systemic viral delivery and tumor targeting, bringing a revolution in molecular medicine and in applications of gene therapy in humans.Keywords
This publication has 85 references indexed in Scilit:
- Inhibitory effect of adenovirus-uteroglobin transduction on the growth of lung cancer cell linesCancer Gene Therapy, 2003
- Long-lasting gene expression by particle-mediated intramuscular transfection modified with bupivacaine: combinatorial gene therapy with IL-12 and IL-18 cDNA against rat sarcoma at a distant siteCancer Gene Therapy, 2003
- Efficiency of Onco-Retroviral and Lentiviral Gene Transfer into Primary Mouse and Human B-Lymphocytes Is Pseudotype DependentHuman Gene Therapy, 2003
- Adenoviral Vector-Mediated mRTVP-1 Gene Therapy for Prostate CancerHuman Gene Therapy, 2003
- The combination of a chemokine, cytokine and TCR-based T cell stimulus for effective gene therapy of cancerCancer Immunology, Immunotherapy, 2002
- Redirecting Migration of T Cells to Chemokine Secreted from Tumors by Genetic Modification with CXCR2Human Gene Therapy, 2002
- Recombinant Adenovirus Vector Activates and Protects Human Monocyte-Derived Dendritic Cells from ApoptosisHuman Gene Therapy, 2002
- Cancer therapy utilizing an adenoviral vector expressing only E1ACancer Gene Therapy, 2002
- Targeting HER2: Recent developments and future directions for breast cancer patientsSeminars in Oncology, 2001
- The p53 Tumor Suppressor Gene: Structure, Function and Mechanism of Action1999